This Viewpoint proposes a practical framework for accomplishing national health goals that health systems and clinicians can adopt and policy makers can fund.
This cross-sectional study examines whether new formulations of brand-name novel drugs were associated with novel drugs’ sales and/or therapeutic value as well as characterizes new formulations’ approval timing relative to the novel drug’s generic approval.
This decision analytical model of prostate cancer screening programs in the Bahamas evaluates the projected benefit of limited screening programs and the implied resources required for their sustainable implementation.
This cross-sectional study evaluates the association between the COVID-19 pandemic and reported new medical debt from 2018 to 2021 across the US.
This Viewpoint highlights how appeals to self-interest as a means to encourage vaccination have come to prevail in the pandemic, and suggests a transition from this approach to appeals that reclaim a spirit of solidarity.
This cross-sectional study aims to identify the changes in hospital ratings and rankings associated with alternative methodological choices in the calculation of the 2021 Centers for Medicare & Medicaid Services Hospital Compare star ratings.
This cross-sectional study examines changes in the operational financial performance and overall financial viability of US hospitals during the COVID-19 pandemic.
This cross-sectional study examines the prevalence and characteristics of real estate investment trust–owned health care properties in the US health care sector.
This Viewpoint describes the framework of a large COVID-19 research consortium that includes private, public-sector, and academic collaborating institutions.
This cross-sectional study examines the association of hospice use among patients with Alzheimer disease and related dementias with the passage of the US IMPACT Act and implementation of the 2-tier payment system.
This economic evaluation examines the magnitude and trend of prescription drug rebates in commercial markets from 2015 to 2019 and identifies insurance plan factors associated with rebates.